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Abstract
Lead is a potent environmental toxin that has accumulated above its natural level as a result of human activity. Pb cation
shows major affinity towards protein complexation and it has been used as modulator of protein-membrane interactions.
We located the binding sites of Pb(II) with human serum (HSA) and bovine serum albumins (BSA) at physiological
conditions, using constant protein concentration and various Pb contents. FTIR, UV-visible, CD, fluorescence and X-ray
photoelectron spectroscopic (XPS) methods were used to analyse Pb binding sites, the binding constant and the effect of
metal ion complexation on HSA and BSA stability and conformations. Structural analysis showed that Pb binds strongly to
HSA and BSA via hydrophilic contacts with overall binding constants of KPb-HSA=8.2 (60.8)610
4 M
21 and KPb-BSA=7.5
(60.7)610
4 M
21. The number of bound Pb cation per protein is 0.7 per HSA and BSA complexes. XPS located the binding
sites of Pb cation with protein N and O atoms. Pb complexation alters protein conformation by a major reduction of a-helix
from 57% (free HSA) to 48% (metal-complex) and 63% (free BSA) to 52% (metal-complex) inducing a partial protein
destabilization.
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Introduction
Pb is a potent environmental toxin that has accumulated 1000-
fold above its natural level as a result of human activity [1]. Even
though the deadly effects of lead on human health have been
known for many years, the molecular mechanism of Pb toxicity is
poorly understood. It is known that Pb cation mimics the effects of
Ca and Zn at specific molecular targets [2,3]. Lead toxicity has
multifunctional effects on both in vivo and in vitro photosynthetic
CO2 fixation and long term exposure results in reduced leaf
growth, decreased level of photosynthetic pigments, altered
chloroplast structure and decreased enzymatic activity of CO2
assimilation [4,5]. Furthermore, photosynthesis is one of the most
Pb-sensitive process in plants [5]. Therefore to better understand
the interaction of Pb with proteins it was of interest to study the
complexation of Pb with well known model proteins such as
human and bovine serum albumins and determine Pb binding
sites and the effect of metal ion interaction on protein structures in
aqueous solution.
Serum albumins are the major soluble protein constituents of
the circulatory system and have many physiological functions [6].
The most important property of this group of proteins is that they
serve as transporters for a variety of organic and inorganic
compounds including metal ions. BSA (Fig. 1) has been one of the
most extensively studied of this group of proteins, particularly
because of its structural homology with human serum albumin
(HSA). The BSA molecule is made up of three homologous
domains (I, II, III) which are divided into nine loops (L1–L9) by 17
disulfide bonds. The loops in each domain are made up of a
sequence of large-small-large loops forming a triplet. Each domain
in turn is the product of two subdomains (IA, IB, etc.). X-
crystallographic data [7] show that the albumin structure is
predominantly a-helical with the remaining polypeptide occurring
in turns and extended or flexible regions between subdomains with
no b-sheets. BSA (Fig. 1) has two tryptophan residues that possess
intrinsic fluorescence [8]. Trp-134 in the first domain and Trp-212
in the second domain.Trp-212 is located within a hydrophobic
binding pocket of the protein and Trp-134 is located on the
surface of the molecule. HSA (Fig. 1) is a globular protein
composed of three structurally similar domains (I, II and III), each
containing two subdomains (A and B) and stabilized by 17
disulphide bridges [9–10]. Aromatic and heterocyclic ligands were
found to bind within two hydrophobic pockets in subdomains IIA
and IIIA, namely site I and site II [8–10]. Seven binding sites for
fatty acids are localized in subdomains IB, IIIA, IIIB and on the
subdomain interfaces [8]. While there are marked similarities
between BSA and HSA in their compositions (Fig. 1), HSA has
only one tryptophan residue Trp-214, while BSA contains two
tryptophan Trp-212 and Trp-134 as fluorophores.
Fluorescence quenching is considered as a useful method for
measuring binding affinities. Fluorescence quenching is the
decrease of the quantum yield of fluorescence from a fluorophore
induced by a variety of molecular interactions with quencher
molecule [11]. Therefore, using the quenching of the intrinsic
tryptophan fluorescence of BSA (Trp-212 and Trp-134) and HSA
(Trp-214) as a tool allows us to study the interaction of lead cation
with serum proteins in an attempt to characterize the nature of Pb-
protein complexation.
PLoS ONE | www.plosone.org 1 May 2012 | Volume 7 | Issue 5 | e36723In this report, we present spectroscopic analysis and XPS study
of the interaction of Pb(II) with HSA and BSA in aqueous solution
at physiological conditions, using constant protein concentration
and various metal ion contents. Structural information regarding
Pb binding site and the effect of metal-protein complexation on
the stability and conformation of HSA and BSA is also reported
here.
Materials and Methods
Materials
HSA and BSA fraction V and PbCl2 were purchased from
Sigma Chemical Company (St-Louise, MO) and used as supplied.
Other chemicals were of reagent grades and used as supplied.
Preparation of stock solutions
Protein (BSA or HSA) was dissolved in aqueous solution
(40 mg/ml or 0.5 mM) containing 10 mM Tris-HCl buffers
(pH 7.2). The protein concentration was determined spectropho-
tometrically using the extinction coefficient of 36 500 M
21 cm
21
at 280 nm [12]. A PbCl2 solution of 1 mM was prepared in
10 mM Tris-HCl and diluted to various concentrations in Tris-
HCl (pH 7.2).
FTIR spectroscopic measurements
Infrared spectra were recorded on a FTIR spectrometer (Impact
420 model), equipped with deuterated triglycine sulphate (DTGS)
detector and KBr beam splitter, using AgBr windows. Solution of
PbCl2 was added dropwise to the protein solution with constant
stirring to ensure the formation of homogeneous solution and to
reach the target Pb concentrations of 0.125, 0.25 and 0.5 mM
with a final protein concentration of 0.25 mM. Spectra were
collected after 2 h incubation of HSA or BSA with Pb solution at
room temperature, using hydrated films. Interferograms were
accumulated over the spectral range 4000–600 cm
21 with a
nominal resolution of 2 cm
21 and 100 scans. The difference
spectra [(protein solution+Pb solution)2(protein solution)] were
generated using water combination mode around 2300 cm
21,a s
standard [13]. When producing difference spectra, this band was
adjusted to the baseline level, in order to normalize difference
spectra.
Analysis of protein conformation
Analysis of the secondary structure of HSA and BSA and their
PbCl2 complexes was carried out on the basis of the procedure
previously reported [14]. The protein secondary structure is
determined from the shape of the amide I band, located around
1650–1660 cm
21. The FTIR spectra were smoothed and their
baselines were corrected automatically using Grams AI software.
Thus the root-mean square (rms) noise of every spectrum was
calculated. By means of the second derivative in the spectral region
1700–1600 cm
21 six major peaks for HSA, BSA and complexes
were resolved. The above spectral region was deconvoluted by the
curve-fitting method with the Levenberg-Marquadt algorithm and
the peaks corresponding to a-helix (1660–1654 cm
21), b-sheet
(1637–1614 cm
21), turn (1678–1670 cm
21), random coil (1648–
1638 cm
21) and b-antiparallel (1691–1680 cm
21) were adjusted
and the area was measured with the Gaussian function. The areas
of all the component bands assigned to a given conformation were
then summed up and divided by the total area [15,16]. The curve-
fitting analysis was performed using the GRAMS/AI Version 7.01
software of the Galactic Industries Corporation.
Circular dichroism
CD Spectra of HSA, BSA and their Pb complexes were
recorded with a Jasco J-720 spectropolarimeter. For measurements
in the far-UV region (178–260 nm), a quartz cell with a path
length of 0.01 cm was used in nitrogen atmosphere. Protein
concentration was kept constant (12.5 mM), while varying PbCl2
concentrations (0.125, 0.25 and 0.5 mM). An accumulation of
three scans with a scan speed of 50 nm per minute was performed
and data were collected for each nm from 260 to 180 nm. Sample
temperature was maintained at 25uC using a Neslab RTE-111
circulating water bath connected to the water-jacketed quartz
cuvettes. Spectra were corrected for buffer signal and conversion
to the Mol CD (De) was performed with the Jasco Standard
Analysis software. The protein secondary structure was calculated
using CDSSTR, which calculates the different assignments of
secondary structures by comparison with CD spectra, measured
from different proteins for which high quality X-ray diffraction
data are available [17,18]. The program CDSSTR is provided in
CDPro software package which is available at the website: http://
lamar.colostate.edu/,sreeram/CDPro.
Fluorescence spectroscopy
Fluorimetric experiments were carried out on a Varian Cary
Eclipse. Solutions containing PbCl2 1 to 100 mM in Tris-HCl
(pH=7.4) were prepared at room temperature (2461uC).
Solutions of HSA and BSA containing 7.5 mM in 10 mM Tris-
HCl (pH=7.2) were also prepared at 2461uC. The fluorescence
spectra were recorded at lexc=280 nm and lem from 287 to
500 nm. The intensity at 347 nm (tryptophan) was used to
calculate the binding constant (K) according to previous literature
reports [19–24].
On the assumption that there are (n) substantive binding sites for
quencher (Q) on protein (B), the quenching reaction can be shown
as following.
nQzBuQnB ð1Þ
The binding constant (KA), can be calculated as:
KA~
QnB ðÞ
Q ½ 
n B ½ 
ð2Þ
Where [Q] and [B] are the quencher and protein concentration,
respectively, [QnB] is the concentration of non fluorescent
fluorophore_quencher complex and [B0] gives total protein
concentration.
Figure 1. Three-dimensional structures of HSA and BSA with
tryptophan residues in green color.
doi:10.1371/journal.pone.0036723.g001
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KA~
B0 ½  { B ½  ðÞ
Q ½ 
n B ½ 
ð4Þ
The fluorescence intensity is proportional to the protein concen-
tration as describe:
B ½  = B0 ½  ?F=F0 ð5Þ
Results from fluorescence measurements can be used to estimate
the binding constant of Pb-protein complex. From eq 4:
log F0{F ðÞ =F ½  ~log KAznlog Q ½  ð6Þ
The accessible fluorophore fraction (f) can be calculated by
modified Stern-Volmer equation.
F0= F0{F ðÞ ~1= fK Q ½  ðÞ z1=f ð7Þ
Where F0 is initial fluorescence intensity and F is fluorescence
intensities in the presence of quenching agent (or interacting
molecule). K is the Stern-Volmer quenching constant, [Q] is the
molar concentration of quencher and f is the fraction of accessible
fluorophore to a polar quencher, which indicates the fractional
fluorescence contribution of the total emission for an interaction
with a hydrophobic quencher [11]. The plot of F0/(F02F) vs 1/
Figure 2. FTIR spectra in the region of 1800–600 cm
21 of hydrated films (pH 7.4) for free BSA (0.25 mM) and its Pb complexes (A)
and for free HSA (0.25 mM) and its Pb complexes (B) with difference spectra (diff.) (bottom two curves) obtained at different Pb
concentrations (indicated on the figure).
doi:10.1371/journal.pone.0036723.g002
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21 as the intercept on y axis and (fK )
21 as the slope.
Thus, the ratio of the ordinate and the slope gives K.
X-ray photoelectron spectroscopy
XPS was performed on a Kratos Axis Ultra spectrometer
(Kratos Analytical Ltd., UK), using a monochromatic Al Ka X-ray
source (k=1486.6 eV) with a power of 225 W, at a take-off angle
of 90 degree relative to the sample surface. Two 250 mM of the
sample was dropped on an aluminum substrate and dried in
vacuum desiccator overnight to obtain a thin film. The dried
sample was then transferred to the XPS sample holder. The
measurements were made under a high vacuum of 10
29 torr, at
room temperature. The surface of the sample was 20 mm
2, and
the investigated area was typically 192 mm
2. Survey spectra for
each sample over a binding energy range of 0–1300 eV were an
average of three scans (at three different points) acquired at pass
energy of 160 eV and resolution of 1 eV/step (lens in hybrid
mode, which assures maximum sensitivity). High-resolution
spectra of C 1 s, N 1 s and O 1 s were an average of five scans
acquired at a pass energy of 40 eV and resolution of 0.1 eV/step,
for quantitative measurements of binding energy and atomic
concentration. Because of the potential degradation of the surface
during X-ray exposure, the spectra were collected in the same
order (survey, C 1 s, O 1 s, N 1 s) such that the amount exposure
to X-rays was equivalent for all analyzed samples. The CasaXPS
software was used for background subtraction (Shirley-type), peak
integration, fitting and quantitative chemical analysis. The C 1 s
(C–C) peak at 285 eV was used to calibrate the binding energy
scale. Binding energies values are given at 60.2 eV. Gaussian
peak profiles were used for spectral deconvolution of C 1 s, O 1 s
and N 1 s spectra [25–28].
Results and Discussion
FTIR and CD spectra of Pb complexes with HSA and BSA
The Pb(II) complexation with HSA and BSA was characterized
by infrared spectroscopy and its derivative methods. The spectral
shifting and intensity variations of protein amide I band at 1656–
1655 cm
21 (mainly C=O stretch) and amide II band at 1547–
1543 cm
21 (C-N stretching coupled with N-H bending modes)
[14,15,29] were monitored upon Pb interaction. The difference
spectra [(protein solution+PbCl2 solution)2(protein solution)] were
obtained, in order to monitor the intensity variations of these
vibrations and the results are shown in Figure 2. Similarly, the
infrared self-deconvolution with second derivative resolution
enhancement and curve-fitting procedures [14] were used to
determine the protein secondary structures in the presence of Pb
cations (Figure 3 and Table 1).
At low Pb(II) concentration (0.125 mM), decrease of intensity
was observed for the protein amide I at 1656–1655 and amide II
Figure 3. Second derivative resolution enhancement and
curve-fitted amide I region (1700–1600 cm
21) for free BSA
and HSA (0.25 mM) and their Pb complexes with 0.5 mM Pb
concentration.
doi:10.1371/journal.pone.0036723.g003
Table 1. Secondary structure analysis (infrared spectra) for the free HSA and BSA and their Pb complexes in hydrated film at
pH 7.4.
Amide I (cm
21) components free BSA (%) 0.25 mM Pb (%) 0.5 mM free HSA (%) 0.25 mM Pb (%) 0.5 mM
a-helix (64) 1654–1660 63 52 57 48
b-sheet (62) 1614–1637 16 15 14 11
random (61) 1638–1648 6 9 12 24
turn (62) 1970–1678 12 17 13 17
b-antiparallel (61) 1680–1691 3 7 4 10
doi:10.1371/journal.pone.0036723.t001
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21, in the difference spectra of the Pb-BSA and
Pb-HSA complexes (Figs. 2A and 2B, diff. 0.125 mM). The
negative features located in the difference spectra for amide I and
II bands at 1656, 1561 cm
21 (Pb-BSA) and 1654, 1547 cm
21 (Pb-
HSA) are due to the loss of intensity of amide I and amide II bands
upon Pb interaction (Fig. 2A and 2B, diff., 0.125 mM). This
reduction of the intensity for the amide I and amide II bands is due
to Pb binding to protein C=O, C-N and N-H groups. Additional
evidence to support the Pb interactions with C-N and N-H groups
comes from the shifting of the protein amide A band at 3300 cm
21
(N-H stretching) in the free HSA and BSA to higher frequency at
3310–3315 cm
21 upon lead cation interaction (spectra not
shown). As Pb concentration increased to 0.5 mM, strong negative
features were observed for amide I band at 1655, 1528 cm
21 (Pb-
BSA) and at 1652 (negative band), 1557 cm
21 (positive band) (Pb-
HSA), upon Pb complexation (Figs. 2A and 2B, diff, 0.5 mM). In
addition, spectral shifting and splitting were observed for the
amide I from 1656 to 1659 cm
21 (Pb-BSA) and from 1655 to
1663 cm
21 (Pb-HSA) in the spectra of Pb-protein complexes
(Fig. 2A and 2B, 0.5 mM complexes). The observed shifting and
splitting of amide I band are due to Pb cation binding to protein
C-O and C-N groups, while the decrease in the intensity of the
amide I band in the spectra of the Pb-protein complexes suggests a
major reduction of protein a-helical structure at high metal ion
concentrations [30].
A quantitative analysis of the protein secondary structure for the
free HSA, BSA and their Pb complexes in hydrated films has been
carried out and the results are shown in Figure 3 and Table 1. The
free HSA has 57% a-helix (1656 cm
21), ß-sheet 14% (1628 and
1617 cm
21), turn structure 13% (1669 cm
21), ß-antiparallel 4%
(1689 cm
21) and random coil 12% (1637 cm
21) (Fig. 3C and
Table 1) consistent with the spectroscopic studies of human serum
albumin [15,20]. The free BSA contains a-helix 63%
(1656 cm
21), ß-sheet 16% (1612 and 1626 cm
21), turn 12%
Table 2. Secondary structure of HSA and BSA complexes (pH 7.4) with Pb cation calculated by CDSSTR Software (CD spectra).
Components conformation free BSA (%) 12.5 mM Pb (%) 0.5 mM free HSA (%) 12.5 mM Pb (%) 0.5 mM
a-helix (63) 60 50 55 45
b-sheet (62) 14 17 16 19
turn (61) 10 15 14 16
random (62) 16 18 15 20
doi:10.1371/journal.pone.0036723.t002
Figure 4. Fluorescence emission spectra of Pb-BSA systems in
10 mM Tris-HCl buffer pH 7.4 at 256C presented for (A) Pb–
BSA: (a) free BSA (7.5 mM), (b–j) with Pb cationl at 1, 2.5, 5, 7.5,
10, 15, 20, 30, 40 and 60 mM; (B) Pb– HSA: (a) free HSA (7.5 mM),
(b–i) Pb at 1, 2.5, 5, 7.5, 10, 15, 20, 30, 40 and 60 mM. Inset: F0/
(F02F) vs 1/[Pb] for A9 (Pb-BSA) and B9 (Pb-HSA).
doi:10.1371/journal.pone.0036723.g004
Figure 5. Stern-Volmer plots of fluorescence quenching
constant (Kq) for the Pb-BSA and Pb-HSA complexes at
different Pb concentrations (A) Pb-BSA and (B) Pb-HSA.
doi:10.1371/journal.pone.0036723.g005
Pb-Protein Binding
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21), ß-antiparallel 3% (1691 cm
21) and random coil 6%
(1638 cm
21) (Fig. 3A and Table 1) consistent with the conforma-
tion of BSA reported [31,32]. Upon Pb cation interaction, a major
decrease of a-helix from 57% (free HSA) to 48% (Pb complex)
with an increase in the turn structure from 13% to 17% (Pb
complex) were observed (Fig. 3D and Table 1). Similarly, for BSA,
a major decrease of a-helix from 63% (free BSA) to 52% (complex)
with an increase in the turn structure from 12% to 17% (Pb
complex) were observed upon Pb complexation (Fig. 3B and
Table 1).
CD spectra
The conformational changes observed from infrared results for
HSA and BSA and their Pb complexes are consistent with CD
spectroscopic analysis shown in Table 2. The CD results show that
free BSA has a high a-helix content 60%, b-sheet 14%, turn 10%
and random coil 16% (Table 2), consistent with the literature
report [33]. The free HSA contains a-helix 55%, b-sheet 16%,
turn 14% and random coil 15% (Table 2). Upon Pb cation
complexation, major reduction of a-helix was observed from 60%
in free BSA to 50% in Pb-BSA and from 55% to 45% in the Pb-
HSA complexes (Table 2). The decrease in a-helix was
accompanied by an increase in the b-sheet, turn and random
coil structures (Table 2). The major reduction of the a-helix with
an increase in the b-sheet, turn and random structures are
consistent with the infrared results, indicating a partial protein
destabilization (Tables 1 and 2).
Fluorescence spectra and stability of Pb complexes with
HSA and BSA
HSA contains a single polypeptide of 585 amino acids with only
one tryptophan (Trp-214) located in subdomain II A. BSA
contains two tryptophan residues Trp-134 and Trp-212 located in
the first and second domains of protein hydrophobic regions.
Tryptophan emission dominates both HSA and BSA fluorescence
spectra in the UV region. The decrease of fluorescence intensity of
HSA and BSA has been monitored at 347 nm for Pb-protein
Figure 6. The plot of Log (F02F/F) as a function of Log (Pb
concentration).
doi:10.1371/journal.pone.0036723.g006
Figure 7. XPS spectra of C atoms for the free HSA and BSA and their Pb complexes.
doi:10.1371/journal.pone.0036723.g007
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system). The plot of F0/(F02F) vs 1/[Pb] (Fig. 4A9 and 4B9 show
representative plots for Pb-protein complexes). Assuming that the
observed changes in fluorescence come from the interaction
between Pb cation and HSA or BSA, the quenching constant can
be taken as the binding constant of the complex formation. The K
values given here are averages of four-replicate and six-replicate
runs for Pb-protein systems, each run involving several different
Pb cation concentrations (Fig. 4A and 4B). The binding constants
obtained were KPb-HSA=8.2 (60.8)610
4 M
21 and KPb-BSA=7.5
(60.7)610
4 M
21 (Fig. 4A9 and 4B9). The association constants
calculated for the Pb complexes suggest strong affinity for Pb-
protein binding, compared to the other ligand-protein adducts
[33,34].
In order to verify the presence of static or dynamic quenching in
Pb-protein complexes we have plotted F0/F against Q and the
results are show in Fig. 5. The plot of F0/F versus Q is linear for
Pb-BSA and Pb-HSA adducts indicating that the quenching is
mainly static in these Pb-protein complexes [24]. The Kq was
estimated according to the Stern-Volmer equation:
Figure 8. XPS spectra of O atoms for the free HSA and BSA and their Pb complexes.
doi:10.1371/journal.pone.0036723.g008
Figure 9. XPS spectra of N atoms for the free HSA and BSA and their Pb complexes.
doi:10.1371/journal.pone.0036723.g009
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where F0 and F are the fluorescence intensities in the absence and
presence of quencher, [Q] is the quencher concentration and KD is
the Stern-Volmer quenching constant (Kq), which can be written as
KD=k qt0; where kQ is the bimolecular quenching rate constant and
t0 is the lifetime of the fluorophore in the absence of quencher,
5.9 ns for BSA and 5.6 ns for HSA [10,23,24]. The quenching
constants (Kq) are 2.5610
11 M
21/s for Pb-BSA and
4.2610
11 M
21/s for Pb-HSA complexes (Fig. 5). Since these
values are much greater than the maximum collisional quenching
constant (2.0610
10 M
21/s), thus the static quenching is dominant
in these Pb-protein complexes [35].
The number of Pb cation bound per protein (n) is calculated
from log [(F02F)/F]=log KS+n log [Pb] for the static quenching
[35–40]. The linear plot of log [(F02F]/F] as a function of log
[Pb] is shown in Figure 6A and 6B. The n values from the slope of
the straight line are 0.7 for Pb-HSA and Pb-BSA complexes,
indicating of one Pb cation bound per protein (Fig. 6A and 6B).
XPS studies and Pb-protein binding sites
To determine the Pb-protein binding sites, we have carried out
X-ray photoelectron spectroscopic study. Figures 6, 7 and 8 show
the XPS results. The experimental atomic composition as
determined from the XPS spectral analysis and the calculated
oxygen and nitrogen to carbon (ON/C) ratio for all samples are
presented in Table 3. Table 3 shows the experimental atomic
composition as determined from the XPS spectral analysis and the
calculated oxygen and nitrogen to carbon (ON/C) ratios for all
samples. All XPS spectra reveal that the C, N and O atoms are the
predominant species and they occur at 285, 401 and 532 eV,
respectively (Figs. 7, 8 and 9). The high resolution C-1 (C-C,
C=C and C-H), C-2 (C-NH) and C-3 (C-O) of HSA and BSA are
observed at about 285, 286 and 288 ev respectively (Fig. 7). The
O-1 (C=O), O-2 (O-H) and O-3 (C-O) are located at about 531,
532, 534 ev, respectively (Fig. 8). Finally, N-1 (C-N), N-2 (NH2)
and N-3 (NH3
+) are positioned at 400, 401 and 402 ev,
respectively (Fig. 9). These assignments are consistent with other
literature reports [25–28,41]. Experimental atomic compositions
and O/C and N/C ratios obtained by XPS analysis for BSA,
BSA-Pb, HSA and HSA-Pb are listed in Table 3. The analysis of
data presented in Table 3 shows major changes in the percentages
of carbon, oxygen and nitrogen atoms, while no major changes
observed for sulfur atom (Table 3). It is interesting to note that the
percentages of C, O and N atoms were decreased for BSA upon
Pb complexation, while they increased for HSA on Pb interaction
(Table 3). This could be indicative of a different binding patterns
of Pb cations in BSA and HSA complexes. The major ratio
changes observed for N and O are coming from direct Pb
coordination with nitrogen and oxygen atoms, while the
alterations of C ratios are related to the linkage of C atom to
metal ion bonded N and O atoms (41). The XPS results show
clearly that N and O atoms are the major metal ion binding sites
in these Pb-protein complexes.
Conclusion
Pb cations bind strongly to HSA and BSA via hydrophilic
interactions with overall binding constants of KPb-
HSA=8.6610
4 M
21 and KPb-BSA=7.5610
4 M
21. The polypep-
tide O and N atoms are the main binding sites of Pb cations. Pb
interaction alters protein secondary structure of both HSA and
BSA causing a partial protein destabilization.
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